Therefore, the results for which CHI3L1 levels correlate with total tau and phosphorylated tau levels in DLB groups, suggest that DLB in combination with AD comorbidities promotes astrocytic activation in response to pathologic proteins [87]. This evidence concerns the gene CHI3L1 and Alzheimer disease.